分子诊断的全球市场:季报数据串流(2024年)

本报告考察了全球分子诊断市场，总结了有关市场规模和成长的最新信息，以及世界主要货币的波动如何影响每个市场的实际成长率。

目录

每季的市场预测

• 分子感染疾病(呼吸系统，肝炎，HIV，HAI/败血症，STI，结核，其他的感染疾病)
• 分子肿瘤学(包含CDx及分子组织学的分子化验)
• 分子遗传学的检验(遗传性疾病和NIPT)
• 分子移植
• 分子NAT血库检验
• 分子POC检验
• 分子COVID检验

NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report. All in any edition. This is because this is a quarterly update to markets covered in these reports.

The most up-to-date information for company-wide success.

Buyers will receive data updates after each financial quarter for one year (for a total of four updates ). These comprehensive updates come in an Excel spreadsheet report easily usable by your marketing, business development, product management teams, and company executives.

With this data on hand your company will always have the most up-to-date information on the size and growth of the molecular diagnostics market. Also included in each update is how fluctuations in major global currencies have affected real growth for each of the markets examined. Corporate leadership teams can use the Datastream as a guide to help determine quarterly market share, and to measure your company's growth against the industry as a whole.

Quarterly Market estimates include:

• Molecular Infectious Disease (Respiratory, Hepatitis, HIV, HAIs/Sepsis, STI, TB and Other Infections)
• Molecular Oncology (Molecular Assays including CDx and Molecular Histology)
• Molecular Genetic Testing (Inherited Diseases and NIPT)
• Molecular Transplantation
• Molecular NAT Blood Banking Tests
• Molecular Molecular Point of Care Tests
• Molecular COVID Testing